key: cord-1021904-7mkj8jg3 authors: Kates, Olivia S.; Fisher, Cynthia E.; Stankiewicz‐Karita, Helen C.; Shepherd, Amanda K.; Church, E. Chandler; Kapnadak, Siddhartha G.; Lease, Erika D.; Riedo, Francis X.; Rakita, Robert M.; Limaye, Ajit P. title: Earliest cases of coronavirus disease 2019 (COVID‐19) identified in solid organ transplant recipients in the United States date: 2020-05-08 journal: Am J Transplant DOI: 10.1111/ajt.15944 sha: 8d4a5d5b19cea8dc9bb22c6cb5127a23b0a39114 doc_id: 1021904 cord_uid: 7mkj8jg3 With the rapidly expanding pandemic of SARS‐CoV‐2, there is concern that solid organ transplant recipients will be particularly vulnerable to infection and may experience a more severe clinical course. We report four cases of COVID‐19 in solid organ transplant recipients including recipients of kidney, liver, lung, and heart transplants. We describe each patient's medical history including transplantation history, their clinical presentation and workup, and their course from diagnosis to either hospital discharge or to improvement in symptoms. These reports demonstrate a range of symptoms, clinical severity, and disease course in solid organ transplant recipients with COVID‐19, including two hospitalized patients and two patients managed entirely in the outpatient setting. The acute kidney injury resolved with hydration. His maximal supplemental oxygen requirement was 2 L/min via nasal cannula. The patient's cyclosporine was continued without adjustment. His respiratory symptoms remained mild, and he was discharged home after 6 days. He was contacted 12 days after admission and reported feeling at his baseline. The patient is a 53-year-old woman who underwent bilateral lung transplantation 20 years earlier for chronic obstructive pulmonary disease, and had chronic lung allograft dysfunction not requiring supplemental oxygen. Her history also included multifactorial pancytopenia, heart failure with preserved ejection fraction, transarte- being seen in the clinic, she reported an increase in cough and dyspnea. These symptoms improved the next day with increased volume removal by peritoneal dialysis. She did not develop fevers. Nine days after being seen in the clinic, the patient reported that her cough and dyspnea had improved. She was otherwise at her baseline health. A 74-year-old man underwent heart transplantation 23 years previously, with a medical history also significant for ulcerative colitis, cutaneous basal cell carcinomas, previous cerebrovascular accident for which the patient was taking warfarin, and obstructive sleep apnea for which the patient uses nocturnal bilevel noninvasive mechanical ventilation. The patient takes tacrolimus for maintenance immunosuppression and mesalamine for ulcerative colitis. In the weeks prior to disease onset, the patient visited a local grocery store and coffee shop sporadically but was otherwise relatively isolated and living alone. The patient first noticed a high fever with a maximum temperature of 40°C measured at home. At a clinic visit the following day, he reported no cough, shortness of breath, sore throat, rhinorrhea, nausea, or diarrhea. At the time of evaluation he was afebrile. Oxygen saturation at rest was 95% on ambient air. Exam revealed faint rales at the R lung base. A chest X-ray revealed a stable elevation of the left hemidiaphragm but no new abnormality. RT-PCR testing for SARS-CoV-2 was positive from a nasopharyngeal swab. Testing for other respiratory viruses was negative. The patient returned home following his clinic visit. He was notified of the test result and instructed to self-isolate. Two days after being seen in the clinic, he reported continued intermittent fevers as high as 38.7°C associated with chills, a new mild dry cough and new mild sore throat but no shortness of breath. Seven days after being seen in the clinic, his fevers had resolved. Eleven days after presentation, all symptoms were resolved. These cases demonstrate a range of severity of clinical presentations and course of COVID-19 in SOT recipients, including two patients requiring hospitalization and two managed as outpatients. None of these patients died of the infection, despite risk factors for severe disease including older age, immunosuppression, and other comorbidities. In one case, there was clinical worsening associated with progression of imaging findings around 1 week after symptom onset, which is also described in the experience from China. 20 Only one patient, with the most severe symptoms, received experimental therapy, which was well tolerated. All patients have been followed for at least 1 month with resolution of all symptoms. One patient with a kidney transplant has persistence of elevated serum creatinine above pre-illness baseline. Although immunosuppression is associated with increased se- We acknowledge the small number of patients and short duration of follow-up in this group. We report these early cases of in SOT recipients in the United States to contribute to a broader ef- The authors wish to acknowledge the physicians, nurses, and other clinical and support staff of Evergreen Hospital and University of Washington Montlake Hospital for their service to the patients included in this report. The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation. Due to the nature of this research, participants of this study did not agree for their data to be shared publicly, so supporting data are not available. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression Perioperative presentation of COVID-19 disease in a liver transplant recipient SARS Cov2 infection in a renal transplanted patients. A case report Successful treatment of severe COVID-19 pneumonia in a liver transplant recipient A familial cluster, including a kidney transplant recipient Identification of kidney transplant recipients with coronavirus disease 2019 COVID-19 in a kidney transplant patient Novel coronavirus (SARS-CoV-2) infection in a renal transplant recipient: case report Immunosuppressive therapy maintenance in a kidney transplant recipient SARS-CoV-2 pneumonia: a case report First case of COVID-19 in a kidney transplant recipient treated with belatacept First cases of COVID-19 in heart transplantation from China COVID-19 in post-transplantation patients-report of two cases Fatal outcome in a liver transplant recipient with COVID-19 COVID-19 in kidney transplant recipients COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy Comparative performance of SARS-CoV-2 detection assays using seven different primer/probe sets and one assay kit In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus Clinical progression of patients with COVID-19 in Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States